What are the triggers for adding nonstatin drug therapy to statin therapy in ASCVD patients at very high-risk?
The triggers for adding nonstatin drug therapy to statin therapy in ASCVD patients at very high-risk are defined by threshold LDL-C levels of 70 mg/dL (1.8 mmol/L) on maximal statin therapy.